£145.99

Academic Press Hypoxia-induced Tumor Heterogeneity and Immune Evasion: Clinical Interventions (Novel approaches to overcome cancer resistance to conventional therapies)

Price data last checked 36 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£146 today · cheaper than every other day in the last 2 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 14 days • 14 data points (No recent data available)

Historical
Generating forecast...
£145.99 £138.69 £141.61 £144.53 £147.45 £150.37 £153.29 07 May 2026 10 May 2026 13 May 2026 16 May 2026 20 May 2026

Price Distribution

Price distribution over 14 days • 1 price levels

Days at Price
14 days 0 4 7 11 14 £146 Days at Price

Price Analysis

Most common price: £146 (14 days, 100.0%)

Price range: £146 - £146

Price levels: 1 different prices over 14 days

Description

Hypoxia-induced Tumor Heterogeneity and Immune Evasion: Clinical Interventions explores how hypoxic stress within the tumor microenvironment drives cancer progression, immune escape, and resistance to therapy. This volume integrates foundational and cutting-edge insights into tumor biology, immunology, and therapeutic innovation. The book is structured into five parts, covering tumor heterogeneity, hypoxia-driven mechanisms, immune evasion, clinical diagnostics, and future directions. It brings together global experts to examine how hypoxia shapes tumor evolution, alters immune responses, and influences treatment outcomes. Topics include metabolic reprogramming, angiogenesis, immune suppression, and hypoxia-targeted therapies, with emphasis on translational relevance. This resource benefits researchers, clinicians, and advanced students by offering a comprehensive, up-to-date synthesis of a rapidly evolving field. It supports deeper understanding of tumor complexity and equips readers with knowledge to inform experimental design, clinical strategies, and therapeutic development in oncology. Integrates hypoxia, tumor heterogeneity, and immune evasion to provide a unified framework for understanding resistance mechanisms in cancer Presents cutting-edge research and clinical insights from global experts, offering a comprehensive view of tumor microenvironment dynamics Equips researchers and clinicians with translational strategies to design innovative immunotherapies and improve patient outcomes

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
05 November 2026
Listed Since
22 April 2026

Barcode

No barcode data available

Similar Products You Might Like

Diverse Effects of Hypoxia on Tumor Progression: 345 (Current Topics in Microbiology and Immunology, 345)
86% match

Diverse Effects of Hypoxia on Tumor Progression: 345 (Current Topics in Microbiology and Immunology, 345)

Springer

£107.30 01 Jun 2026
84% match

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Academic Press

£153.99 22 May 2026
Tumor Vascularization
84% match

Tumor Vascularization

Academic Press

£111.89 13 Jun 2026
83% match

Advances in Brain Tumor Therapy: From Molecular Mechanisms to Clinical Practice

Academic Press

£137.99 26 May 2026
An Illustrated Guide to Cancer Biology
83% match

An Illustrated Guide to Cancer Biology

Academic Press

£154.99 06 Jun 2026
Tumor Microenvironment: Cellular, Metabolic and Immunologic Interactions: 1350 (Advances in Experimental Medicine and Biology, 1350)
82% match

Tumor Microenvironment: Cellular, Metabolic and Immunologic Interactions: 1350 (Advances in Experimental Medicine and Biology, 1350)

Springer

£112.85 05 Jun 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
82% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£108.92 10 Jun 2026
Autophagy in tumor and tumor microenvironment
82% match

Autophagy in tumor and tumor microenvironment

Springer

£86.90 05 Jun 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
82% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£179.99 31 May 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
82% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.46 31 May 2026
Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies
82% match

Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies

Academic Press

£141.99 30 May 2026
82% match

Theranostic Approaches in Nuclear Medicine as a Strategy to Overcome Cancer Treatment Resistance (Novel approaches to overcome cancer resistance to conventional therapies)

Academic Press

£137.99 18 May 2026
The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)
82% match

The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)

Springer

£40.40 28 May 2026
Artificial Intelligence for Enhanced Diagnosis in Oncology
82% match

Artificial Intelligence for Enhanced Diagnosis in Oncology

Academic Press

£121.78 28 May 2026
Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)
82% match

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

Humana

£107.98 29 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
82% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 24 May 2026
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
82% match

Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)

Springer

£74.57 31 May 2026
The Tumor Microenvironment: Methods and Protocols: 1458 (Methods in Molecular Biology, 1458)
81% match

The Tumor Microenvironment: Methods and Protocols: 1458 (Methods in Molecular Biology, 1458)

Humana

£80.64 13 Jun 2026
81% match

Multidisciplinary Interventional Oncology

Academic Press

£254.99 26 May 2026
Pioneering Precision in Cancer Treatment through 3D Bioprinting
81% match

Pioneering Precision in Cancer Treatment through 3D Bioprinting

Academic Press

£153.99 23 May 2026
Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy
81% match

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

Academic Press

£157.99 23 May 2026
81% match

Emerging Technologies in Bioengineering for Oncology: Fundamentals, Research, and Future Prospects

Academic Press

£141.99 22 May 2026
The Role of Microenvironment in the Control of Tumor Angiogenesis
81% match

The Role of Microenvironment in the Control of Tumor Angiogenesis

Springer

£86.87 01 Jun 2026
Genomic Instability and Cancer Metastasis: Mechanisms, Emerging Themes, and Novel Therapeutic Strategies: 20 (Cancer Metastasis - Biology and Treatment, 20)
81% match

Genomic Instability and Cancer Metastasis: Mechanisms, Emerging Themes, and Novel Therapeutic Strategies: 20 (Cancer Metastasis - Biology and Treatment, 20)

Springer

£86.87 03 Jun 2026